Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma

Showing NaN - NaN of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma Trial in Worldwide (Bendamustine, Rituximab, Ibrutinib)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +201 more
Jan 27, 2023

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (GEN3009, Epcoritamab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • +7 more
  • GEN3009
  • Epcoritamab
  • Tucson, Arizona
  • +31 more
Jul 1, 2022

Collecting and Storing Tissue Samples From Rare or Cutaneous

Active, not recruiting
  • Adult Immunoblastic Lymphoma
  • +12 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +129 more
Mar 23, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +9 more
  • NKX019
  • Denver, Colorado
  • +6 more
Jan 19, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Denver, Colorado
  • +3 more
May 20, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Denver, Nashville, Houston (TC-110 T

Recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • TC-110 T Cells
  • +2 more
  • Denver, Colorado
  • +2 more
Jun 25, 2020

Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)

Terminated
Has Results
  • Mantle Cell Lymphoma
  • Non-Hodgkin's Lymphoma
  • San Diego, California
  • +91 more
Nov 6, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Denmark, Germany, United States

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +6 more
  • Denver, Colorado
  • +10 more
Oct 10, 2019

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +127 more
Jan 8, 2018

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Australia, Canada, United States (Bendamustine, Rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +42 more
Apr 7, 2014

Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)

Completed
  • Mantle Cell Lymphoma
  • VELCADE TM (bortezomib) for Injection
  • Birmingham, Alabama
  • +34 more
Feb 7, 2008